Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Koichiro Ogihara"'
Autor:
Hiroki Ide, Eiji Kikuchi, Koichiro Ogihara, Naoya Niwa, Keisuke Shigeta, Tsukasa Masuda, Yuto Baba, Ryuichi Mizuno, Mototsugu Oya
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Limited information is currently available on predictors of upper tract urothelial carcinoma (UTUC) recurrence in non-muscle-invasive bladder cancer (NMIBC) patients according to smoking history, although smoking probably contributes to urot
Externí odkaz:
https://doaj.org/article/7984864f958c4dd8a754a4a8907ca7d8
Autor:
Tetsushi Murakami, Eiji Kikuchi, Hiroki Ide, Yuta Umezawa, Takayuki Takahashi, Mizuki Izawa, Kyohei Hakozaki, Keisuke Shigeta, Koichiro Ogihara, Hiroaki Kobayashi, Kunimitsu Kanai, Takahiro Maeda, Shunsuke Yoshimine, Ryuichi Mizuno, Koshiro Nishimoto, Mototsugu Oya
Publikováno v:
BJUI Compass, Vol 2, Iss 5, Pp 322-330 (2021)
Abstract Objective To investigate whether dose reductions in cisplatin due to renal dysfunction were associated with worse clinical outcomes in metastatic urothelial carcinoma (UC) patients. Patients and methods One hundred and fifty one metastatic U
Externí odkaz:
https://doaj.org/article/db48cc315c304f1080449bd09f6518ad
Autor:
Minami Omura, Eiji Kikuchi, Keisuke Shigeta, Koichiro Ogihara, Kyohei Hakozaki, Satoshi Hara, Suguru Shirotake, Hiroki Ide, Shunsuke Yoshimine, Takashi Ohigashi, Ryuichi Mizuno, Mototsugu Oya
Publikováno v:
Japanese Journal of Clinical Oncology. 52:388-396
Background Although the administration of neoadjuvant chemotherapy has been associated with improved prognosis in patients with muscle-invasive bladder cancer, the therapeutic effects of adjuvant chemotherapy remain unknown in real-world settings. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b736667a3cc42feeef5954c9cdc8079
https://doi.org/10.1093/jjco/hyab210
https://doi.org/10.1093/jjco/hyab210
Autor:
Keisuke Shigeta, Hiroaki Kobayashi, Mototsugu Oya, Takayuki Takahashi, Kunimitsu Kanai, Kyohei Hakozaki, Ryuichi Mizuno, Koichiro Ogihara, Yuta Umezawa, Koshiro Nishimoto, Takahiro Maeda, Shunsuke Yoshimine, Mizuki Izawa, Hiroki Ide, Eiji Kikuchi, Tetsushi Murakami
Publikováno v:
BJUI Compass, Vol 2, Iss 5, Pp 322-330 (2021)
Objective To investigate whether dose reductions in cisplatin due to renal dysfunction were associated with worse clinical outcomes in metastatic urothelial carcinoma (UC) patients. Patients and methods One hundred and fifty one metastatic UC patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7548297294fe26d170299ed450f4d0e8
https://doaj.org/article/db48cc315c304f1080449bd09f6518ad
https://doaj.org/article/db48cc315c304f1080449bd09f6518ad
Autor:
Ryuichi Mizuno, Yasuaki Murata, Yui Nishimoto, Koichiro Ogihara, Mototsugu Oya, Masafumi Oyama, Eiji Kikuchi, Keisuke Shigeta, Hirotaka Asakura, Yuto Baba, Masashi Matsushima
Publikováno v:
International Journal of Clinical Oncology. 26:2094-2103
The effects of the type of anesthesia (spinal (SA) vs. general (GA)) used for transurethral resection of bladder tumor (TURBT) on non-muscle invasive bladder cancer (NMIBC) recurrence and progression are controversial and our aim is to investigate th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e0d91025e7bd661b602c9724bb672d9
https://doi.org/10.1007/s10147-021-02000-z
https://doi.org/10.1007/s10147-021-02000-z
Autor:
Yoshinori Yanai, Ryuichi Mizuno, Takeshi Masuda, Mototsugu Oya, Masafumi Oyama, Shintaro Hasegawa, Keisuke Shigeta, Tadatsugu Anno, Kimiharu Takamatsu, Keitaro Watanabe, Eiji Kikuchi, Koichiro Ogihara
Publikováno v:
Japanese Journal of Clinical Oncology. 51:984-991
Background It currently remains unclear whether the location of primary tumours affects the clinical outcomes of patients with locally advanced urothelial carcinoma in the urinary tract. The aim of the present study was to compare prognostic differen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23c0ee3a8a6ca0456805af96fbf92662
https://doi.org/10.1093/jjco/hyab003
https://doi.org/10.1093/jjco/hyab003
Autor:
Tansei Sanjo, Yuto Baba, Shuji Mikami, Mototsugu Oya, Takayuki Abe, Eiji Kikuchi, Masayuki Hagiwara, Kota Umeda, Keisuke Shigeta, Koichiro Ogihara, Ryuichi Mizuno, Tadatsugu Anno, Kazunori Shojo
Publikováno v:
European Urology Oncology. 3:756-763
Background The current guideline lacks evidence for creating individualized surveillance strategies for upper tract urothelial carcinoma (UTUC) patients after radical nephroureterectomy (RNU). Objective To create a novel risk model and to simulate in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6df8fb0c5a481483089d38161895c423
https://doi.org/10.1016/j.euo.2019.06.021
https://doi.org/10.1016/j.euo.2019.06.021
Autor:
Eiji Kikuchi, Nobuyuki Tanaka, Shinya Morita, Hiroshi Asanuma, Koichiro Ogihara, Kazuhiro Matsumoto, Kimiharu Takamatsu, Shuji Mikami, Takeo Kosaka, Toshikazu Takeda, Nozomi Hayakawa, Mototsugu Oya, Masafumi Oyama, Ryuichi Mizuno
Publikováno v:
International Urology and Nephrology. 53:465-469
Intravesical bacillus Calmette–Guerin (BCG) is the standard of care for bladder carcinoma in situ (CIS). The response to BCG therapy against CIS is generally assessed by random bladder biopsy (RBB). In this study, we examined the necessity of routi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f8348ad45e5be741c7e87bfe641ea80
https://doi.org/10.1007/s11255-020-02667-9
https://doi.org/10.1007/s11255-020-02667-9
Autor:
Eiji Kikuchi, Takeo Kosaka, Toshikazu Takeda, Kazuhiro Matsumoto, Hideyuki Saya, Mototsugu Oya, Shuji Mikami, Shogo Okazaki, Koichiro Ogihara, Masayuki Hagiwara
Publikováno v:
Cancer Science
The prognostic role of CD44v9, a variant isoform of CD44 and a new cell surface marker of cancer stem cells, remains unclear in bladder cancer (BC) patients. Furthermore, limited information is available on the functional role of sulfasalazine (SSZ),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44521ba0b476793734b55a52ff359af2
https://doi.org/10.1111/cas.13960
https://doi.org/10.1111/cas.13960
Autor:
Tomohiro Iwasawa, Eiji Kikuchi, Kyohei Hakozaki, Mototsugu Oya, Keisuke Shigeta, Emina Kayama, Kunimitsu Kanai, Hiroki Ide, Koichiro Ogihara, Ken Kamisawa, Satoshi Hara, Ryuichi Mizuno
Publikováno v:
Japanese journal of clinical oncology. 51(8)
Background The relationship between guideline adherence for radical cystectomy of non-muscle-invasive bladder cancer and patient prognoses currently remains unclear. We investigated whether guideline adherence at the time of non-muscle-invasive bladd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c66808208c15608bb4ef9cafdea9f19
https://pubmed.ncbi.nlm.nih.gov/34009374
https://pubmed.ncbi.nlm.nih.gov/34009374